Pediatric Hospitalizations for COVID-19 Increasing Across US States
There is significant variation across states in the rates of pediatric hospitalization for COVID-19, but the average cumulative hospitalization rate is increasing.
Home
Obstetric Complications Common Among Women Who Develop Systemic Sclerosis
Researchers evaluated obstetric complications in women with a systemic sclerosis diagnosis vs the general obstetric population.
Oral Glucose Tolerance Test Recommended With Low-Dose Glucocorticoids
The purpose of this study was to assess the prevalence and risk factors of new-onset glucose metabolism impairment in patients with normal fasting glycemia on long-term glucocorticoid treatment to determine which patients should undergo an oral glucose tolerance test.
FDA: False Results Possible With Curative SARS-Cov-2 Test
The FDA is alerting patients and health care providers regarding the risk of false negatives for COVID-19 when using the Curative SARS-Cov-2 test.
Jaw Osteonecrosis Linked to Treatment for Bone Metastases
The cumulative three-year incidence of osteonecrosis of the jaw is 2.8% in cancer patients receiving zoledronic acid for metastatic bone disease.
Gaps Found in Opioid Use Disorder Treatment During the COVID-19 Pandemic
Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic.
Make Rheum for Mental Health in Pediatric Rheumatology
In this episode, we discuss the importance of addressing mental health in the pediatric rheumatology population.
Long-Term Effects of Secukinumab on Fatigue in Ankylosing Spondylitis
Study authors assessed the long-term effects of secukinumab on fatigue in patients with ankylosing spondylitis in the MEASURE 1 and MEASURE 2 trials.
Unmet Pain Management Needs Are Evident in Axial Spondyloarthritis
Investigators compared differences in pain reports between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis to assess how pain sensitivity was associated with disease and health outcomes.
Rituximab Plus Cyclophosphamide Followed by Belimumab Safe for Refractory Lupus Nephritis Treatment
Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus nephritis.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Systemic Lupus Erythematosus
